Лучшие подкасты про Per Spectives (2024)

1
S2 Ep15: PER®Spectives: Advancing Treatment in nAMD and DME with Novel Therapies 18:11

3M ago18:11

18:11

This PER®Spectives™ podcast examines opportunities for extended treatment intervals associated with newer therapies for patients with neovascular age-related macular degeneration or diabetic macular edema. In this podcast, experts Arshad Khanani, MD, Ferhina Ali, MD, and Michael Singer, MD, offer real-world data and personal insights into the use o…

1
S2 Ep14: Postpartum Depression: A Multidisciplinary Approach to Management 11:46

4M ago11:46

11:46

This podcast explores the diagnosis and management of postpartum depression with a focus on the importance of screening all postpartum women and treatment options. Two faculty, Sarah Nagle-Yang, MD, and Lindsey Lebin, MD, discuss the importance of an early diagnosis with each other, and a patient shares her journey living with postpartum depression…

1
S2 Ep13: Patient, Provider, and Caregiver Connection™: Developing Strategies to Improve Patient Access to Care for Thalassemia - Understanding Patient Challenges and the Role of Innovative Treatment 35:14

4M ago35:14

35:14

This podcast explores the management of thalassemia with a focus on the disease burden, current therapy, and emerging gene therapy. Two faculty, Hanny Al-Samkari, MD, and Kevin H.M. Kuo, MD, MSc, FRCPC, discuss with each other and with a patient sharing their journey living with thalassemia. Faculty Hanny Al-Samkari, MD Classical Hematologist and C…

1
S2 Ep12: Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management 21:10

5M ago21:10

21:10

This podcast features engaging commentary from experts in the clinical management of generalized myasthenia gravis— James Howard, Jr, MD and Nicholas Sylvestri, MD. These experts discuss the burden of disease associated with the disorder, its pathogenesis in terms of the complement system, and the clinical considerations for incorporating appropria…

1
S2 Ep11: Advances in Topical Treatment for Presbyopia 24:11

8M ago24:11

24:11

This PER®Spectives™ podcast examines treatment of presbyopia with a focus on new and emerging topical therapies. In this podcast, experts Mile Brujic, OD, FAAO, and Jay Pepose, MD, PhD, describe these agents and how to select patients with presbyopia who will benefit from topical treatment. Faculty: Mile Brujic, OD, FAAO Premier Vision Group Bowlin…

1
S2 Ep10: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care 27:52

8M ago27:52

27:52

Optometrists play a critical role in first-line screening and monitoring of patients with neovascular age-related macular degeneration (or nAMD) and diabetic macular edema (or DME). Where patients require more advanced care, optometrists refer them to retina specialists. Join Drs Ferhina Ali, Carl Regillo, Jessica Steen and Mohammad Rafieetary as t…

1
S2 Ep9: Clinical Pearls in Co-Managing Glaucoma 12:13

9M ago12:13

12:13

This PER® Spectives™ featured podcast examines the important role of co-management of glaucoma between optometrists and ophthalmologists .Expert faculty review the selection of traditional and novel topical therapies, and also patient selection for micro-incisional glaucoma surgery (MIGS). Faculty Danica J. Marrelli, OD, FAAO, AAO College of Optome…

1
S2 Ep8: Advances in Treatment for Geographic Atrophy 28:33

9M ago28:33

28:33

This podcast provides a review of some of the key highlights from the Controversies in Modern Eye Care meeting held in April 2023. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did. Faculty David S. Boyer, MD Retina-Vitreous Associates Medical Group Los Angeles, CA Tina Mac Donal…

1
S2 Ep7: Looking at the Lid – Reducing Patient Burden in Blepharoptosis & Demodex Blepharitis 14:51

10M ago14:51

14:51

Welcome to a podcast based on learning about the lid: optimizing recognition, diagnosis, and treatment of Demodex Blepharitis and Blepharoptosis. In this podcast, we will hear from Dr Mile Brujic and Dr Cecelia Koetting. Faculty Mile Brujic, OD, FAAO Partner Premier Vision Group Bowling Green, OH Cecelia Koetting, OD, FAAO, DipABO Optometrist Denve…

1
S2 Ep6: Thyroid Eye Disease: The Masquerading Eye Disorder - A Guide to Accurate Diagnosis & Collaborative Care 25:51

10M ago25:51

25:51

In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients. Faculty Steven Leibowitz, MD Associate Clinical Professor, Oculoplastics and Orbit Jules Stein Eye Institu…

1
S2 Ep5: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis 30:33

10M ago30:33

30:33

In this podcast, two experts discuss the diagnosis and treatment of Parkinson disease psychosis. In their conversation, they discuss examples of patients they have encountered. They also discuss the results of recent clinical trials of new therapies and the importance of a multispecialty approach for these patients. Faculty Gus Alva, MD, DFAPA Medi…

1
S2 Ep4: Catching and Addressing Early Neurotropic Keratitis: New Perspectives 14:17

10M ago14:17

14:17

Neurotrophic keratitis (NK) is a rare condition caused by trigeminal nerve damage, which results in decreased or absent corneal sensitivity and breakdown of the corneal epithelium. If not recognized and managed appropriately, it can lead to corneal ulceration and loss of vision. However, early diagnosis and treatment can improve outcomes. This feat…

1
S2 Ep3: Facing the Changing Landscape for Neuromodulators and Dermal Fillers 24:39

1y ago24:39

24:39

Thanks for your interest in this podcast. Please read this important program information before listening. Access to the posttest and instructions for claiming credit for participating are included below. This PER® Spectives™ podcast examines the recent increase in the demand for dermal fillers and neuromodulators, and the corresponding increase in…

1
S2 Ep2: Addressing Healthcare Inequities™: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis 58:39

1y ago58:39

58:39

Thanks for your interest in this podcast. Please read this important program information before listening. Access to the post-test and to claim credit for participating is included below. This PER® Spectives™ podcast includes a discussion with 3 experts on health disparities that negatively impact patients with cystic fibrosis (CF). Access to care,…

1
S2 Ep1: MGD-Associated Dry Eye Disease – How Emerging Options May Shift the Treatment Paradigm 18:42

1y ago18:42

18:42

Meibomian gland dysfunction (MGD) is a complex, multifactorial disorder that can lead to altered tear film composition and ocular surface disease. In fact, MGD is one of the most common causes of dry eye disease (DED). Although multiple treatment options are available, therapies that target the underlying pathophysiology of the disease are lacking.…

1
S1 Ep9: Advances in Sickle Cell Disease Management 29:34

1y ago29:34

29:34

This podcast features engaging commentary from experts in the clinical management of patients with sickle cell disease: Nirmish Shad, MD from Duke University Medical Center, Matthew Heeney, MD Matthew Heeney, MD from Harvard Medical School, and Charles R. Jonassaint, PhD, MHS from University of Pittsburgh School of Medicine. These experts review cl…

1
S1 Ep8: Part 1 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Dara Aisner MD, PhD 18:02

1+ y ago18:02

18:02

Our ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable altera…

1
S1 Ep8: Part 2 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with David Gandara MD 7:48

1+ y ago7:48

7:48

Our ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable altera…

1
S1 Ep8: Part 3 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Charu Aggarwal MD, MPH 6:13

1+ y ago6:13

6:13

Our ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable altera…

1
S1 Ep8: Part 4 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Julia Rotow MD 17:18

1+ y ago17:18

17:18

Our ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable altera…

1
S1 Ep7: Part 5 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Balazs Halmos MD, MS 10:07

1+ y ago10:07

10:07

Our ever-advancing understanding of oncogenic drivers in non–small cell lung cancer (NSCLC) has led to an expanding armamentarium of targeted therapy options. Given the availability of recently emerging, highly efficacious treatments, it is more important than ever that patients with NSCLC undergo comprehensive testing to identify targetable altera…

1
S1 Ep6: Tumor Board: Bridging Current Practices and New Therapeutic Developments in ER-Positive Breast Cancer 49:22

2y ago49:22

49:22

During this educational Tumor Board, breast cancer specialists will showcase challenging scenarios in metastatic and non-metastatic HR+ disease and contextualize data from pivotal clinical trials to optimize decision-making for patients with HR+/HER2- breast cancer. Featuring: Fátima Cardoso, MD Director, Breast Unit Champalimaud Clinical Center Li…

1
S1 Ep5: Managing Your Patients with CKD 45:26

2y ago45:26

45:26

Dr. Eden Miller and Kim Zuber, PA-C, discuss the importance of screening patients with chronic kidney disease (CKD) for comorbidities and treating them early. They also discuss the treatment options available among both current and emerging classes of therapies and across different clinical subspecialties. After you listen to this podcast, go to ht…

1
S1 Ep4: What You Need to Know About the Evolving Role of TIL Therapy in Cancer Treatment 23:04

2y ago23:04

23:04

Tumor-infiltrating lymphocyte (TIL) is an emerging therapy that may one day change the approach to the management of solid tumors including melanoma, NSCLC, and more. Join us for a conversation with Dr. Omid Hamid, one of the principal investigators pioneering TIL therapy in clinical trials, as we discuss this novel treatment method. Dr. Hamid will…

Подкасты, которые стоит послушать

Подкасты на тему Per Spectives

Подкасты, которые стоит послушать

1
PER Spectives

PER® Spectives

1
S2 Ep15: PER®Spectives: Advancing Treatment in nAMD and DME with Novel Therapies 18:11

1
S2 Ep14: Postpartum Depression: A Multidisciplinary Approach to Management 11:46

1
S2 Ep13: Patient, Provider, and Caregiver Connection™: Developing Strategies to Improve Patient Access to Care for Thalassemia - Understanding Patient Challenges and the Role of Innovative Treatment 35:14

1
S2 Ep12: Generalized Myasthenia Gravis: Improving Patient Outcomes Through Early Diagnosis and Management 21:10

1
S2 Ep11: Advances in Topical Treatment for Presbyopia 24:11

1
S2 Ep10: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care 27:52

1
S2 Ep9: Clinical Pearls in Co-Managing Glaucoma 12:13

1
S2 Ep8: Advances in Treatment for Geographic Atrophy 28:33

1
S2 Ep7: Looking at the Lid – Reducing Patient Burden in Blepharoptosis & Demodex Blepharitis 14:51

1
S2 Ep6: Thyroid Eye Disease: The Masquerading Eye Disorder - A Guide to Accurate Diagnosis & Collaborative Care 25:51

1
S2 Ep5: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis 30:33

1
S2 Ep4: Catching and Addressing Early Neurotropic Keratitis: New Perspectives 14:17

1
S2 Ep3: Facing the Changing Landscape for Neuromodulators and Dermal Fillers 24:39

1
S2 Ep2: Addressing Healthcare Inequities™: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis 58:39

1
S2 Ep1: MGD-Associated Dry Eye Disease – How Emerging Options May Shift the Treatment Paradigm 18:42

1
S1 Ep9: Advances in Sickle Cell Disease Management 29:34

1
S1 Ep8: Part 1 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Dara Aisner MD, PhD 18:02

1
S1 Ep8: Part 2 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with David Gandara MD 7:48

1
S1 Ep8: Part 3 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Charu Aggarwal MD, MPH 6:13

1
S1 Ep8: Part 4 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Julia Rotow MD 17:18

1
S1 Ep7: Part 5 of 5: Top 10 Oncogenic Markers in NSCLC for 2022: An interview with Balazs Halmos MD, MS 10:07

1
S1 Ep6: Tumor Board: Bridging Current Practices and New Therapeutic Developments in ER-Positive Breast Cancer 49:22

1
S1 Ep5: Managing Your Patients with CKD 45:26

1
S1 Ep4: What You Need to Know About the Evolving Role of TIL Therapy in Cancer Treatment 23:04

Краткое руководство